Abstract:Lipid droplets (LDs) with own interface architecture not only play crucial roles in protecting cell from lipotoxicity and lipoapoptosis but also closely relate with many diseases such as fatty liver and diabetes. Thus, as one of important applied biomaterials, fluorescent probes with ultrahigh selectivity for in-situ and high-fidelity imaging LDs in living cells and tissues are critical to elucidate relevant physiological and pathological events as well as detect related diseases. However, available LDs probes only utilizing their waterless neutral cores but ignoring the unique phospholipid monolayer interfaces exhibit low selectivity. Particularly, current probes cannot discriminate neutral cores of LDs from intracellular other lipophilic microenvironments, so that extensively cloud-like background fluorescence diffusing in cytoplasm, which severely limited their applications. Herein, in order to design LDs probes with ultrahigh selectivity, the exceptionally interfacial architecture of LDs is considered adequately and thus an interface-targeting strategy is proposed for the first time. According to the novel strategy, we have developed two amphipathic fluorescent probes (N-Cy and N-Py) by introducing different cations into a lipophilic fluorophore (NBD). Consequently, their cationic moiety precisely locates the interfaces through electrostatic interaction and simultaneously NBD entirely embeds into the waterless core via hydrophobic interaction. Thus high-fidelity and background-free fluorescence imaging of LDs is expectably realized in living cells in-situ. Moreover, LDs in turbid tissues like skeletal muscle slices have been clearly imaged (up to 82 μm depth) in two-photon microscope. Importantly, using N-Cy, we not only intuitively monitored the variations of LDs in number, size and morphology, but also clearly revealed their abnormity in hepatic tissues resulted from fatty liver. Therefore, these unique probes provide excellent imaging tools for elucidating LDs-related physiological and pathological processes, and the interface-targeting strategy possesses universal significance for designing probes with ultrahigh selectivity.

A turn-on fluorescent probe for lipid-targeting imaging in human arterial aneurysm and fibrocalcific stenotic aortic valve

A lipid activated color switchable probe for the imaging of diseased aortic valves

Nitrobenzoxadiazole based lipid droplets specific probes for atherosclerosis imaging

Interface-targeting strategy enables two-photon fluorescent lipid droplets probes for high-fidelity imaging turbid tissues and detecting fatty liver.

Turn-on fluorescent probe for lipid droplet specific imaging of fatty liver and atherosclerosis

A Lipid Activatable Fluorescence Probe for Atherosclerosis Imaging

Engineering of a NIR fluorescent probe for high-fidelity tracking of lipid droplets in living cells and nonalcoholic fatty liver tissues

A stable NIR fluorescent probe for imaging lipid droplets in triple-negative breast cancer

Light-up lipid droplets for the visualization of lipophagy and atherosclerosis by coumarin-derived bioprobe

A triphenylamine-based fluorescent probe with large Stokes shift for wash-free imaging of lipid droplets and diagnosis of fatty liver

A Novel Fluoro-Pyrazine-Bridged Donor-Accepter-Donor Fluorescent Probe for Lipid Droplet-Specific Imaging in Diverse Cells and Superoxide Anion Generation

A Near-Infrared Probe for Specific Imaging of Lipid Droplets in Living Cells

Lipid droplets-specific fluorescent probe for wash-free imaging and in vivo diagnosis of non-alcoholic fatty liver disease

Isophorone-based AIEgens fluorescent probe with red emission for targeting lipid droplets and identifying non-alcoholic fatty liver disease

Fluorescent probes for imaging: a focus on atherosclerosis

Rational design of a two-photon probe with solvatochromic emission and AIE-activity for lipid droplet specific imaging

Lipid droplet-specific near-infrared fluorescent probe for discriminating cancer and normal cells and diagnosing fatty liver

In Vivo Three‐Photon Imaging of Lipids using Ultrabright Fluorogens with Aggregation‐Induced Emission

Specific lipid droplet imaging of atherosclerotic plaques and fatty liver using an imidazole-based fluorescence probe

A pH-responsive nanoplatform with aggregation-induced emission features for lipid droplet imaging in atherosclerosis

Photostable fluorescent probes for 3D imaging and monitoring the metabolism of lipid droplets